These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 4852375)
21. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
22. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling. Bowles GC Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060 [No Abstract] [Full Text] [Related]
23. Anticounterfeit campaigners go back to school. Dolgin E Nat Med; 2010 Apr; 16(4):362. PubMed ID: 20376028 [No Abstract] [Full Text] [Related]
24. Quality assurance for medical products: unified program for all federal agencies. Flaherty FJ Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796 [No Abstract] [Full Text] [Related]
25. [Control of drugs in foreign countries]. Buriánek J; Parrák V Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551 [No Abstract] [Full Text] [Related]
26. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
27. Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule. Fed Regist; 1998 May; 63(91):26066-9. PubMed ID: 10179333 [TBL] [Abstract][Full Text] [Related]
28. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
29. Anticipated revisions to the current good manufacturing practice regulations. Mitchell CM Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938 [No Abstract] [Full Text] [Related]
30. Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 May; 65(103):34082-9. PubMed ID: 11010719 [TBL] [Abstract][Full Text] [Related]
31. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
32. A needed technical fix? Robertson WO Vet Hum Toxicol; 2000 Apr; 42(2):118-9. PubMed ID: 10750184 [No Abstract] [Full Text] [Related]
33. Therapeutic orphans: who speaks for children? Shirkey HC South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304 [No Abstract] [Full Text] [Related]
34. A product standards form for new radipharmaceuticals. Warbick A Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850 [No Abstract] [Full Text] [Related]
35. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-first report. World Health Organ Tech Rep Ser; 1990; 790():1-79. PubMed ID: 2110393 [No Abstract] [Full Text] [Related]
36. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
37. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Grant DJ; Byrn SR Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580 [No Abstract] [Full Text] [Related]
38. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
39. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule. Fed Regist; 1998 May; 63(91):26127-9. PubMed ID: 10179335 [TBL] [Abstract][Full Text] [Related]
40. Drug therapy today: DESI ratings, a revolution in the making. DiPalma JR RN; 1973 Jun; 36(6):51-63. PubMed ID: 4488242 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]